Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Nosocomial Candida bloodstream infections rank among infections with highest mortality rates. A retrospective cohort analysis was conducted at Catholic University Hospital to estimate the risk factors for mortality of patients with candidemia. We reviewed records for patients with a Candida bloodstream infection over a 5-year period (January 2000 through December 2004). Two hundred ninety-four patients (42.1% male; mean age ± standard deviation, 65 ± 12 years) were studied. Patients most commonly were admitted with a surgical diagnosis (162 patients [55.1%]), had a central venous catheter (213 [72.4%]), cancer (118 [40.1%]), or diabetes (58 [19.7%]). One hundred fifty-four (52.3%) patients died within 30 days. Of 294 patients, 168 (57.1%) were infected by Candida albicans , 64 (21.7%) by Candida parapsilosis , 28 (9.5%) by Candida tropicalis , and 26 (8.8%) by Candida glabrata . When fungal isolates were tested for biofilm formation capacity, biofilm production was most commonly observed for isolates of C. tropicalis (20 of 28 patients [71.4%]), followed by C. glabrata (6 of 26 [23.1%]), C. albicans (38 of 168 [22.6%]), and C. parapsilosis (14 of 64 [21.8%]). Multivariable analysis identified inadequate antifungal therapy (odds ratio [OR], 2.35; 95% confidence interval [95% CI], 1.09 to 5.10; P = 0.03), infection with overall biofilm-forming Candida species (OR, 2.33; 95% CI, 1.26 to 4.30; P = 0.007), and Acute Physiology and Chronic Health Evaluation III scores (OR, 1.03; 95% CI, 1.01 to 1.15; P < 0.001) as independent predictors of mortality. Notably, if mortality was analyzed according to the different biofilm-forming Candida species studied, only infections caused by C. albicans ( P < 0.001) and C. parapsilosis ( P = 0.003) correlated with increased mortality. Together with well-established factors, Candida biofilm production was therefore shown to be associated with greater mortality of patients with candidemia, probably by preventing complete organism eradication from the blood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multivariate analysis identified three factors associated with mortality: inadequate antifungal therapy, infection with biofilm-forming Candida species, and Apache III score.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Nosocomial Candida bloodstream infections (BSIs), with an estimated annual incidence in the United States of 6 to 10 candidemia episodes per 100,000 population, have become a considerable public health concern (24, 25, 29).”
BackgroundCDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 5×
“Of 294 patients with Candida BSIs (mean age standard deviation, 65 12 years; 42.1% male), 262 cases (89.1”
BackgroundInfluentialFriedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
Cited by
Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., et al. (2009) · Chest · doi:10.1378/chest.09-0087 · Cited by 1,187
Candida parapsilosis, an Emerging Fungal Pathogen
Trofa, D., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 854
Development and regulation of single- and multi-species Candida albicans biofilms
Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
Our Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483
Septic shock attributed to Candida infection: Importance of empiric therapy and source control.
Kollef, M., Micek, S., Hampton, N., Doherty, J. A., & Kumar, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis305 · Cited by 477
“Source control has previously been shown to be an important determinant of outcome for patients with serious infections attributed to Candida species [31, 32].”
BackgroundDel Pozo, J. L. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1417036 · Cited by 453
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389
Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366
Candida parapsilosis: from genes to the bedside
Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327
Candida sp. Infections in Patients with Diabetes Mellitus
Rodrigues, C., Rodrigues, M., & Henriques, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010076 · Cited by 315
Candida albicans biofilms and polymicrobial interactions
Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R., & Richardson, J. P. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843400 · Cited by 281
Roscetto, E., Contursi, P., Vollaro, A., Fusco, S., Notomista, E., & Catania, M. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-35530-0 · Cited by 272
de Groot, P. W. J., Kraneveld, E. A., Yin, Q. Y., Dekker, H. L., Groß, U., Crielaard, W., de Koster, C. G., Bader, O., Klis, F. M., & Weig, M. (2008) · Eukaryotic Cell · doi:10.1128/ec.00284-08 · Cited by 232
“For instance, cell wall components mediate tissue adhesion and invasion, provide protection against host defense reactions, are involved in biofilm formation, trigger the host immune response, and may also confer resistance to antifungal drugs (15, 17, 41, 45, 48, 62 , 69).”
BackgroundRajendran, R., Sherry, L., Nile, C. J., Sherriff, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. J., & Ramage, G. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.018 · Cited by 228
“Biofilm formation has been reported as an independent predictor of mortality, in addition to inadequate antifungal therapy and APACHE III scores [8].”
BackgroundResultSpanu, T., Posteraro, B., Fiori, B., D'Inzeo, T., Campoli, S., Ruggeri, A., Tumbarello, M., Canu, G., Trecarichi, E. M., Parisi, G., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05742-11 · Cited by 213
Self-citationBassetti, M., Righi, E., Ansaldi, F., Merelli, M., Scarparo, C., Antonelli, M., Garnacho-Montero, J., Diaz-Martin, A., Palacios-Garcia, I., Luzzati, R., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3866-2 · Cited by 208
Self-citationBiofilm formation in clinical Candida isolates and its association with virulence
Hasan, F., Xess, I., Wang, X., Jain, N., & Fries, B. C. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.018 · Cited by 206
Candida biofilms and oral candidosis: treatment and prevention
Williams, D. W., Kuriyama, T., Silva, S., Malic, S., & Lewis, M. A. O. (2011) · Periodontology 2000 · doi:10.1111/j.1600-0757.2009.00338.x · Cited by 205
Epidemiology and treatment approaches in management of invasive fungal infections
Ito, J. I., Kriengkauykiat, Dadwal, S., & Kriengkauykiat (2011) · Clinical Epidemiology · doi:10.2147/clep.s12502 · Cited by 204
Tumbarello, M., Fiori, B., Trecarichi, E. M., Posteraro, P., Losito, A. R., De Luca, A., Sanguinetti, M., Fadda, G., Cauda, R., & Posteraro, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033705 · Cited by 197
Self-citationReactive Oxygen Species-Inducing Antifungal Agents and Their Activity Against Fungal Biofilms
Delattin, N., Cammue, B. P., & Thevissen, K. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.189 · Cited by 189
Posteraro, B., De Pascale, G., Tumbarello, M., Torelli, R., Pennisi, M. A., Bello, G., Maviglia, R., Fadda, G., Sanguinetti, M., & Antonelli, M. (2011) · Critical Care · doi:10.1186/cc10507 · Cited by 185
Self-citationPolke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in Applied Microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 184
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C., Appanna, V. D., Singh, R., Saunders, D. P., & Tharmalingam, S. (2023) · Cells · doi:10.3390/cells12222655 · Cited by 180
Invasive Mycoses: Diagnostic Challenges
Ostrosky-Zeichner, L. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.008 · Cited by 176
Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1338-7 · Cited by 173
“[15] retrospectively studied the risk factors for mortality of patients with candidemia.”
BackgroundCandida glabrata: pathogenicity and resistance mechanisms for adaptation and survival
Hassan, Y., Chew, S. Y., & Than, L. T. L. (2021) · Journal of Fungi · doi:10.3390/jof7080667 · Cited by 170
“In addition, they are involved in biofilm formation, triggering the host immune response, and may confer resistance to antifungal drugs [36,37].”
BackgroundContributions of the Biofilm Matrix to Candida Pathogenesis
Nett, J. E., & Andes, D. R. (2020) · Journal of Fungi · doi:10.3390/jof6010021 · Cited by 157
The Interface between Fungal Biofilms and Innate Immunity
Kernien, J. F., Snarr, B. D., Sheppard, D. C., & Nett, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01968 · Cited by 142
Biofilm formation by five species of Candida on three clinical materials
Estivill, D., Arias, Á., Lana, Á. T., Carrillo‐Muñoz, A. J., & Arévalo, M. P. (2011) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2011.05.019 · Cited by 137
Sherry, L., Rajendran, R., Lappin, D. F., Borghi, E., Perdoni, F., Falleni, M., Tosi, D., Smith, K., Williams, C., Jones, B., et al. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-182 · Cited by 134
Walraven, C. J., & Lee, S. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01351-12 · Cited by 132
Tackling Fungal Resistance by Biofilm Inhibitors
Wu, S., Wang, Y., Liu, N., Dong, G., & Sheng, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01203 · Cited by 132
MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond
Posteraro, B., De Carolis, E., Vella, A., & Sanguinetti, M. (2013) · Expert Review of Proteomics · doi:10.1586/epr.13.8 · Cited by 128
Self-citationMakiura, N., Ojima, M., Kou, Y., Furuta, N., Okahashi, N., Shizukuishi, S., & Amano, A. (2008) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2007.00426.x · Cited by 128
Pierce, C. G., Chaturvedi, A. K., Lazzell, A. L., Powell, A. T., Saville, S. P., McHardy, S. F., & Lopez-Ribot, J. L. (2015) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2015.12 · Cited by 124
Thomaz, D. Y., de Almeida, J. N., Lima, G. M. E., Nunes, M. D. O., Camargo, C. H., Grenfell, R. D. C., Benard, G., & Del Negro, G. M. B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02997 · Cited by 124
Candida tropicalis in human disease
Ann Chai, L. Y., Denning, D. W., & Warn, P. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.489506 · Cited by 122
Fungal diagnosis: how do we do it and can we do better?
Perfect, J. R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761134 · Cited by 124
León, C., Ostrosky-Zeichner, L. L., & Schuster, M. G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3281-0 · Cited by 118
Fungal Biofilms: Relevance in the Setting of Human Disease
Martinez, L. R., & Fries, B. C. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0035-5 · Cited by 115
Arastehfar, A., Daneshnia, F., Hilmioğlu-Polat, S., Fang, W., Yaşar, M., Polat, F., Metin, D. Y., Rigole, P., Coenye, T., Ilkit, M., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01001-20 · Cited by 110
Pannanusorn, S., Fernandez, V., & Römling, U. (2012) · Mycoses · doi:10.1111/myc.12014 · Cited by 110
Recent advances in delivery of antifungal agents for therapeutic management of candidiasis
Sawant, B., & Khan, T. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.127 · Cited by 112
Prevalence of biofilms in Candida spp. bloodstream infections: A meta-analysis
Atiencia-Carrera, M. B., Cabezas-Mera, F. S., Tejera, E., & Machado, A. (2022) · PLOS ONE · doi:10.1371/journal.pone.0263522 · Cited by 107
Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms
Mitchell, K. F., Taff, H. T., Cuevas, M. A., Reinicke, E. L., Sanchez, H., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02378-12 · Cited by 104
Pinhati, H. M. S., Casulari, L. A., Souza, A. C. R., Siqueira, R. A., Damasceno, C. M. G., & Colombo, A. L. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1767-9 · Cited by 102
The effect of biomaterials and antifungals on biofilm formation by Candida species: a review
Cuéllar‐Cruz, M., Vega‐González, A., Mendoza‐Novelo, B., López-Romero, E., Ruiz‐Baca, E., Escorza, M. A. Q., & Villagómez-Castro, J. C. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1634-6 · Cited by 104
Strength in numbers: antifungal strategies against fungal biofilms
Ramage, G., Robertson, S. N., & Williams, C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.023 · Cited by 103
Alnuaimi, A. D., O'Brien-Simpson, N. M., Reynolds, E. C., & McCullough, M. J. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12068 · Cited by 84
Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia
Arnold, H. M., Micek, S. T., Shorr, A. F., Zilberberg, M. D., Labelle, A. J., Kothari, S., & Kollef, M. H. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.4.361 · Cited by 94
Chang, W., Liu, J., Zhang, M., Shi, H., Zheng, S., Jin, X., Gao, Y., Wang, S., Ji, A., & Lou, H. (2018) · Nature Communications · doi:10.1038/s41467-018-07633-9 · Cited by 91
Fu, J., Ding, Y., Wei, B., Wang, L., Xu, S., Qin, P., Liuhua, W., & Jiang, L. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2423-8 · Cited by 89
Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital
Muñóz, P., Giannella, M., Fanciulli, C., Guinea, J., Valerio, M., Rojas, L., Rodríguez‐Créixems, M., & Bouza, E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03338.x · Cited by 93
Activity of caffeic acid derivatives against Candida albicans biofilm
Vita, D. D., Friggeri, L., D’Auria, F. D., Pandolfi, F., Piccoli, F., Panella, S., Palamara, A. T., Simonetti, G., Scipione, L., Santo, R. D., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.02.005 · Cited by 87
Biofilm formation by oral clinical isolates of Candida species
Sánchez-Vargas, L. O., Estrada-Barraza, D., Pozos‐Guillén, A., & Rivas-Caceres, R. (2013) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2013.06.006 · Cited by 87
Secretion of E , E -Farnesol and Biofilm Formation in Eight Different Candida Species
Weber, K., Sohr, R., Schulz, B., Fleischhacker, M., & Ruhnke, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01646-07 · Cited by 85
Pathogenic factors in Candida biofilm-related infectious diseases
Hirota, K., Yumoto, H., Sapaar, B., Matsuo, T., Ichikawa, T., & Miyake, Y. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13330 · Cited by 83
Rajendran, R., Sherry, L., Deshpande, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. L., & Ramage, G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00915 · Cited by 81
Ding, X., Yan, D., Sun, W., Zeng, Z., Su, R., & Su, J. (2015) · Medical Mycology · doi:10.1093/mmy/myv060 · Cited by 81
Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections
Kischkel, B., Rossi, S. A., Santos, S. R. D., Nosanchuk, J. D., Travassos, L. R., & Taborda, C. P. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00463 · Cited by 81
Candida Species: New Insights into Biofilm Formation
Cuéllar-Cruz, M., López-Romero, E., Villagómez-Castro, J. C., & Ruiz-Baca, E. (2012) · Future Microbiology · doi:10.2217/fmb.12.48 · Cited by 80
“albicans able to form biofilms [57].”
BackgroundAbi-chacra, É. A., Souza, L. O. P., Cruz, L. P. S., Braga-Silva, L. A., Gonçalves, D. D. S., Sodré, C. L., Dornelas-Ribeiro, M., Seabra, S. H., Figueiredo‐Carvalho, M. H. G., Barbedo, L. S., et al. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12092 · Cited by 80
Rajkowska, K., Nowicka-Krawczyk, P. B., & Kunicka‐Styczyńska, A. (2019) · Molecules · doi:10.3390/molecules24101954 · Cited by 80
Weber, K., Schulz, B., & Ruhnke, M. (2010) · Yeast · doi:10.1002/yea.1769 · Cited by 79
Novel strategies to fightCandidaspecies infection
Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 80
Candidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 78
How Biofilm Growth Affects Candida-Host Interactions
Eix, E. F., & Nett, J. E. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01437 · Cited by 77
Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 76
Proteomics of drug resistance in Candida glabrata biofilms
Seneviratne, C. J., Wang, Y., Jin, L., Abiko, Y., & Samaranayake, L. P. (2010) · PROTEOMICS · doi:10.1002/pmic.200900611 · Cited by 74
Neji, S., Hadrich, I., Trabelsi, H., Abbes, S., Cheikhrouhou, F., Sellami, H., Makni, F., & Ayadi, A. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0376-2 · Cited by 73
Fiori, B., Posteraro, B., Torelli, R., Tumbarello, M., Perlin, D. S., Fadda, G., & Sanguinetti, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-10 · Cited by 73
Self-citationCharacterization of Candida parapsilosis complex isolates
Toro, M., Torres, M. J., Ruíz, M., & Aznar, J. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03302.x · Cited by 74
Fungal biofilms in human health and disease
Ramage, G., Kean, R., Rautemaa-Richardson, R., Williams, C., & Lopez-Ribot, J. L. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01147-0 · Cited by 72
Effect of alkylphospholipids on Candida albicans biofilm formation and maturation
Vila, T. V. M., Ishida, K., de Souza, W., Prousis, K., Calogeropoulou, T., & Rozental, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks353 · Cited by 71
El-Houssaini, H. H., Elnabawy, O. M., Nasser, H. A., & Elkhatib, W. F. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.12.028 · Cited by 71
Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults
Bow, E. J., Evans, G., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R., Shafran, S. D., Sheppard, D., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 70
Zuza-Alves, D. L., de Medeiros, S. S. T. Q., de Souza, L. B. F. C., Rocha, W. P. D. S., Francisco, E. C., de Araújo, M. C. B., de Lima-Neto, R. G., Neves, R. P., Melo, A. S. D. A., & Chaves, G. M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01783 · Cited by 70
Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors
Vila, T. V. M., & Lopez-Ribot, J. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02006-16 · Cited by 68
Liu, C. Y., Huang, L. J., Wang, W. S., Chen, T. L., Yen, C. C., Yang, M. H., Hsiao, L. T., Liu, C. Y., Chen, P. M., & Chiou, T. J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2008.12.008 · Cited by 67
Cordeiro, R. D. A., Teixeira, C. E. C., Brilhante, R. S. N., Castelo‐Branco, D. D. S. C. M., de Alencar, L. P., de Oliveira, J. S., Monteiro, A. J., Bandeira, T. J. P. G., Sidrim, J. J. C., Moreira, J. L. B., et al. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov012 · Cited by 67
Angoulvant, A., Guitard, J., & Hennequin, C. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov114 · Cited by 67
Ding, L., Xia, R., Zhang, Q., Bai, C., Li, Z., & Zhang, P. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2636-x · Cited by 67
Lohse, M. B., Gulati, M., Craik, C. S., Johnson, A. D., & Nobile, C. J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01027 · Cited by 67
Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation
Rajendran, R., Sherry, L., Lappin, D. F., Nile, C. J., Smith, K., Williams, C., Munro, C. A., & Ramage, G. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0303-6 · Cited by 66
Simitsopoulou, M., Peshkova, P., Tasina, E., Katragkou, A., Kyrpitzi, D., Velegraki, A., Walsh, T. J., & Roilides, E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02541-12 · Cited by 66
Swindell, K., Lattif, A. A., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/600106 · Cited by 64
You, J., Du, L., King, J. B., Hall, B. E., & Cichewicz, R. H. (2013) · ACS Chemical Biology · doi:10.1021/cb400009f · Cited by 64
Soldini, S., Posteraro, B., Vella, A., Carolis, E. D., Borghi, E., Falleni, M., Losito, A. R., Maiuro, G., Trecarichi, E. M., Sanguinetti, M., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.11.005 · Cited by 64
Self-citationRisk Factors of Candida parapsilosis Catheter-Related Bloodstream Infection
Yamin, D. H., Husin, A., & Harun, A. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.631865 · Cited by 63
The Impact of Biofilm Formation on the Persistence of Candidemia
Li, W.-S., Chen, Y.-C., Kuo, S.-F., Chen, F.-J., & Lee, C.-H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01196 · Cited by 62
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 62
Borecká‐Melkusová, S., Moran, G. P., Sullivan, D. J., Kucharíková, S., Chorvát Jr, D., & Bujdáková, H. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01550.x · Cited by 61
Chow, B. D. W., Linden, J. R., & Bliss, J. M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.74 · Cited by 62
Tulasidas, S., Rao, P., Bhat, S., & Manipura, R. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s179462 · Cited by 60
Tellapragada, C., Eshwara, V. K., Johar, R., Shaw, T., Malik, N., Bhat, P. V., Kamath, A., & Mukhopadhyay, C. (2014) · Journal of Pathogens · doi:10.1155/2014/142864 · Cited by 58
Candidemia: species involved, virulence factors and antimycotic susceptibility.
Luca, C. D., Guglielminetti, M. L., Ferrario, A., Calabr, M., & Casari, E. (2012) · PubMed · Cited by 58
Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Bassetti, M., Mikulska, M., & Viscoli, C. (2010) · Critical Care · doi:10.1186/cc9239 · Cited by 57
Tavanti, A., Hensgens, L. A., Mogavero, S., Majoros, L., Senesi, S., & Campa, M. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-203 · Cited by 56
Metadata
- Authors
- Tumbarello, M., Posteraro, B., Trecarichi, E. M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., Cauda, R., & Sanguinetti, M.
- Affiliations
- Institutes of Infectious Diseases
- Università Cattolica del Sacro Cuore (IT)
- Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2007-06
- Volume
- 45
- Issue
- 6
- Pages
- 1843-1850
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC1933062
- OpenAlex
- W1976891952
- Cited by
- 343
- References
- 46
- Citations by year
- 2026: 15 · 2025: 9 · 2024: 9 · 2023: 12 · 2022: 12 · 2021: 23 · 2020: 21 · 2019: 14 · 2018: 19 · 2017: 27 · 2016: 25 · 2015: 20 · 2014: 23 · 2013: 24 · 2012: 22
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, mortality risk factors, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida glabrata, APACHE III score, nosocomial bloodstream infection, central venous catheters, antifungal susceptibility testing, Candida parapsilosis complex
- MeSH terms
- Aged, Antifungal Agents, Candida, Candidiasis, Female, Hospitals, University, Humans, Italy, Male, Microbial Sensitivity Tests, Middle Aged, Predictive Value of Tests, Risk Factors, Fungemia, Biofilms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.